Discovering potential pathways between type 2 diabetes mellitus and diabetic retinopathy: A big data analysis of the South Korean National Sample Cohort

Diabetes mellitus, a prevalent metabolic disorder, is associated with a multitude of complications that necessitate vigilant management post-diagnosis. A notable complication, diabetic retinopathy, could lead to intense ocular injury, including vision impairment and blindness, due to the impact of the disease. Studying the transition from diabetes to diabetic retinopathy is paramount for grasping and halting the progression of complications. In this study, we examine the statistical correlation between type 2 diabetes mellitus and retinal disorders classified elsewhere, ultimately proposing a comprehensive disease network. The National Sample Cohort of South Korea, containing approximately 1 million samples and primary diagnoses based on the International Statistical Classification of Diseases and Related Health Problems 10th Revision classification, was utilized for this retrospective analysis. The diagnoses of both conditions displayed a statistically significant correlation with a chi-square test value of P < .001, and the t test for the initial diagnosis date also yielded a P < .001 value. The devised network, comprising 27 diseases and 142 connections, was established through statistical evaluations. This network offers insight into potential pathways leading to diabetic retinopathy and intermediary diseases, encouraging medical researchers to further examine various risk factors associated with these connections.

[1]  S. Yoshida,et al.  Role of interferons in diabetic retinopathy , 2021, World journal of diabetes.

[2]  I. Miron,et al.  Otitis Media and Obesity—An Unusual Relationship in Children , 2021, Healthcare.

[3]  Dandan Song,et al.  Association of non‐alcoholic fatty liver disease with diabetic retinopathy in type 2 diabetic patients: A meta‐analysis of observational studies , 2020, Journal of diabetes investigation.

[4]  James P. Smith,et al.  The Veterans Affairs Continuous Positive Airway Pressure Use and Diabetic Retinopathy Study. , 2019, Optometry and vision science : official publication of the American Academy of Optometry.

[5]  D. Kim,et al.  Diabetes and the Risk of Infection: A National Cohort Study , 2019, Diabetes & metabolism journal.

[6]  J. Chen,et al.  Presence of diabetic retinopathy is lower in type 2 diabetic patients with non-alcoholic fatty liver disease , 2019, Medicine.

[7]  L. Ji,et al.  The association of smoking and risk of diabetic retinopathy in patients with type 1 and type 2 diabetes: a meta-analysis , 2018, Endocrine.

[8]  Timothy P. Fox,et al.  RELATIONSHIP BETWEEN OBSTRUCTIVE SLEEP APNEA AND THE PRESENCE AND SEVERITY OF DIABETIC RETINOPATHY , 2017, Retina.

[9]  L. Ye,et al.  Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus , 2017, Medicine.

[10]  D. Ting,et al.  Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a review , 2016, Clinical & experimental ophthalmology.

[11]  A. Barkmeier,et al.  The Role of Systemic Risk Factors in Diabetic Retinopathy , 2016, Current Ophthalmology Reports.

[12]  J. S. Lee,et al.  Cohort Profile Cohort Profile : The National Health Insurance Service – National Sample Cohort ( NHIS-NSC ) , South Korea , 2017 .

[13]  Maureen A. Smith,et al.  Rheumatoid arthritis and the prevalence of diabetic retinopathy. , 2015, Rheumatology.

[14]  W. B. Leong,et al.  The Potential Association between Obstructive Sleep Apnea and Diabetic Retinopathy in Severe Obesity—The Role of Hypoxemia , 2013, PloS one.

[15]  C. Jung,et al.  Prevalences of diabetic retinopathy and nephropathy are lower in Korean type 2 diabetic patients with non‐alcoholic fatty liver disease , 2013, Journal of diabetes investigation.

[16]  C. Alves,et al.  Infections in patients with diabetes mellitus: A review of pathogenesis , 2012, Indian journal of endocrinology and metabolism.

[17]  R. Klein,et al.  Projection of diabetic retinopathy and other major eye diseases among people with diabetes mellitus: United States, 2005-2050. , 2008, Archives of ophthalmology.

[18]  H. Koh,et al.  Objective evaluation of cataract progression associated with a high dose intravitreal triamcinolone injection , 2008, Eye.

[19]  M. Rashidi,et al.  Prevalence of dry eye syndrome and diabetic retinopathy in type 2 diabetic patients , 2008, BMC ophthalmology.

[20]  S. Yamagishi,et al.  Role of advanced glycation end products (AGEs) and oxidative stress in diabetic retinopathy. , 2008, Current pharmaceutical design.

[21]  Paul Mitchell,et al.  The eye in hypertension , 2007, The Lancet.

[22]  C. Hanis,et al.  Genetics of diabetic retinopathy , 2006, Current diabetes reports.

[23]  J. Agrawal,et al.  Management of intractable glaucoma following intravitreal triamcinolone acetonide. , 2005, American journal of ophthalmology.

[24]  P. Kaiser,et al.  Acute endophthalmitis following intravitreal triamcinolone acetonide injection. , 2003, American journal of ophthalmology.

[25]  J. Pankow,et al.  Hepatitis C virus infection and incident type 2 diabetes , 2003, Hepatology.

[26]  M. Szklo,et al.  Prevalence of Type 2 Diabetes Mellitus among Persons with Hepatitis C Virus Infection in the United States , 2000, Annals of Internal Medicine.

[27]  G. Alexander,et al.  Association of diabetes mellitus and chronic hepatitis C virus infection , 1999, Hepatology.

[28]  Y. Nagaki,et al.  Interferon associated retinopathy , 1998, The British journal of ophthalmology.

[29]  R. Simó,et al.  High Prevalence of Hepatitis C Virus Infection in Diabetic Patients , 1996, Diabetes Care.

[30]  H. Onuki [Diabetes and infections]. , 1975, Nihon rinsho. Japanese journal of clinical medicine.

[31]  Richard J. Symes,et al.  Hypertensive eye disease: a review , 2017, Clinical & experimental ophthalmology.

[32]  R. Klein,et al.  The Role of Genetics in Susceptibility to Diabetic Retinopathy , 2009, International ophthalmology clinics.

[33]  T. Imaizumi,et al.  Advanced glycation end products (AGEs) and diabetic vascular complications. , 2005, Current diabetes reviews.